Top

Published in:

Open Access 01-12-2017 | Commentary

Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis

Author: Naomi E. Aronson

Published in: BMC Medicine | Issue 1/2017

Abstract

Leishmaniasis is a chronic intracellular parasitic infection that travelers, immigrants, deployed military personnel, and refugees from endemic global areas acquire from the bite of infected sand flies and carry with them, including to non-endemic countries where leishmaniasis may be an unfamiliar illness to medical providers. This commentary discusses the first clinical practice guidelines produced by the Infectious Diseases Society of America and American Society of Tropical Medicine and Hygiene for the diagnosis and management of leishmaniasis, targeted for clinicians in North America.

Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239–43.CrossRefPubMed

Global Trends 2015 [http://www.unhcr.org/en-us/global-trends-2015.html]. Accessed 27 Mar 2017.

Du R, Hotez PJ, Al-Salem WS, Acosta-Serrano A. Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa. PLoS Negl Trop Dis. 2016;10(5):e0004545.CrossRefPubMedPubMedCentral

FP Mockenhaupt, Barbre KA, M Jensenius, CS Larsen, ED Barnett, W Stauffer, C Rothe, H Asgeirsson, DH Hamer, DH Esposito, P Gautret, P Schlagenhauf. Profile of illness in Syrian refugees: a geosentinel analysis, 2013 to 2015. Eurosurveillance. 2016;21(10):30160. doi:10.2807/1560-7917.ES.2016.21.10.30160.

His E, Murshidi MM, Hijjawi MQ, Jeriesat S, Eltom A. Syrian refugees and Jordan’s health sector. Lancet. 2013;382(9888):206–7.CrossRef

Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak. Int J Infect Dis. 2014;29:115–9.CrossRefPubMed

Saroufim M, Charafeddine K, Issa G, Khalifeh H, Habib RH, Berry A, Ghosn N, Rady A, Khalifeh I. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerg Infect Dis. 2014;20(10):1712–5.CrossRefPubMedPubMedCentral

Ozkeklikci A, Karakus M, Ozbel Y, Toz S. The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey. Acta Trop. 2017;166:35–8.CrossRefPubMed

Inci R, Ozturk P, Mulayim MK, Ozyurt K, Alatas ET, Inci MF. Effect of the Syrian civil war on prevalence of cutaneous leishmaniasis in Southeastern Anatolia, Turkey. Med Sci Monit. 2015;21:2100–4.CrossRefPubMedPubMedCentral

10.

Neumayr AL, Morizot G, Visser LG, Lockwood DN, Beck BR, Schneider S, Bellaud G, Cordoliani F, Foulet F, Laffitte EA, et al. Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-alpha antagonists. Travel Med Infect Dis. 2013;11(6):412–20.CrossRefPubMed

11.

van Griensven J, Carrillo E, Lopez-Velez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20(4):286–99.CrossRefPubMed

12.

World Health Organization. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Releve epidemiologique hebdomadaire. 2016;91(22):287–296.

13.

Copeland NK, Aronson NE. Leishmaniasis: treatment updates and clinical practice guidelines review. Curr Opin Infect Dis. 2015;28(5):426–37.CrossRefPubMed

14.

Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017;96(1):24–45.CrossRefPubMedPubMedCentral

15.

Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63(12):e202–64.CrossRefPubMed

Title: Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis
Author: Naomi E. Aronson
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2017
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-017-0843-3

At a glance: The STEP trials

Springer Medicine

Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

Use of malaria rapid diagnostic tests by community health workers in Afghanistan: cluster randomised trial

ING3 promotes prostate cancer growth by activating the androgen receptor

The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort

Group-based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community-based longitudinal study